Stay updated on Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry v3.5.2 and removes the older v3.5.0 entry.
    Difference
    0.1%
    Check dated 2026-04-16T02:10:28.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Added revision v3.5.0 to the Record History and removed v3.4.3 from the history.
    Difference
    0.1%
    Check dated 2026-03-25T07:09:04.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision v3.4.3 was added to the Record History. Revision v3.4.2 was removed.
    Difference
    0.2%
    Check dated 2026-03-10T15:34:51.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    A new revision entry v3.4.2 was added to the history and the previous revision v3.4.1 was removed.
    Difference
    0.1%
    Check dated 2026-02-17T04:17:00.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.1) was added to the record history, and older items—including a funding-lapse notice and the v3.4.0 revision—were removed.
    Difference
    0.9%
    Check dated 2026-02-10T01:22:45.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    A government funding lapse notice appears at the top of the page, informing users that information may not be up to date and providing links to cc.nih.gov and opm.gov.
    Difference
    0.8%
    Check dated 2026-02-02T21:51:35.000Z thumbnail image

Stay in the know with updates to Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial page.